Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CELLINK logo — Create the future of health

CELLINK

Create the future of health

Founded 2016 Sweden Sweden 71 employees IPO Total: $15.94M Biotechnology, Life Sciences +1

General Information

Company Name CELLINK
Founded Year 2016
Location Sweden Sweden
Employees 71
Industries Biotechnology, Life Sciences, 3D Printing
Funding Stage IPO
Social

BounceWatch is an independent company data service, not affiliated with CELLINK. To contact CELLINK, visit cellink.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CELLINK compare?

A PDF of CELLINK and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CELLINK soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CELLINK

CELLINK is a pioneering biotechnology company based in Sweden that is shaping the future of healthcare. Through its parent company, BICO, CELLINK has established itself as a global leader in bioconvergence, enabling breakthroughs in the field of 3D bioprinting. The company democratized access to advanced research tools by introducing the first universal bioink in 2016, a move that catalyzed the exponential growth of the 3D bioprinting industry, now valued at $1 billion. By offering an extensive range of bioinks, bioprinters, software, and services, CELLINK has garnered the trust of leading researchers and top 20 pharmaceutical companies worldwide, with over 1,000 laboratories embracing its cutting-edge innovations. These groundbreaking solutions have been referenced in 700 publications, underscoring their significant impact on the scientific community. In March 2020, CELLINK secured a notable kr2.00M grant investment from Vinnova, further reinforcing its position as a trailblazer in the biotechnology landscape. As part of the BICO bioconvergence movement, CELLINK is dedicated to realizing the potential of on-demand bioprinting of human organs and tissues, thereby shaping the future of health.

Business keywords: bioink technology, 3D printing, human organs, tissue models, medical research, oncology research, drug testing, cosmetic testing, bioprinting innovations, bioprinting technology, Gothenburg, Sweden, Palo Alto, California

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $210.00K 1
Vinnova
Vinnova
01 Mar 2020
Grant €480.00K -
01 Apr 2019
Post-IPO Equity $3.50M 1
Franklin Templeton
Franklin Templeton
01 Oct 2018
Post-IPO Equity €2.50M 1
European Innovation Council
European Innovation Council
01 Jul 2018
Grant €350.00K 1
Horizon 2020 FET (Future and Emerging Technologies)
01 Jun 2017
IPO $8.90M -
01 Oct 2016
Seed Undisclosed 1
Robert Bosch Venture Capital
Robert Bosch Venture Capital
01 Oct 2015

Latest News

View All
Draghi report sounds alarm on Europe's competitive decline — Tech
Draghi report sounds alarm on Europe's competitive decline
Tech Sep 13, 2024

CELLINK Alternatives & Competitors

View All Alternatives
CELLINK vs
VoxCell
VoxCell Canada

Redefining drug development. Replicating human tissues.

Seed
30 employees
Biopharma, Biotechnology
Compare CELLINK vs VoxCell
CELLINK vs
Carcinotech Ltd
Carcinotech Ltd United Kingdom

Enabling Cancer Treatment Breakthroughs

Seed
23 employees
Biotechnology, Life Sciences
Compare CELLINK vs Carcinotech Ltd
CELLINK vs
REGEMAT 3D
REGEMAT 3D Spain

Customized Bioprinting systems and Bioreactors. Creating Life Changing Futures.

Equity Crowdfunding
25 employees
Biotechnology, Manufacturing
View all alternatives

FAQ About CELLINK

Create the future of health
CELLINK was founded in 2016.
CELLINK is headquartered in Sweden.
CELLINK operates in Biotechnology, Life Sciences and 3D Printing. Its work centres on bioink technology, 3D printing, human organs and tissue models.
CELLINK has approximately 71 employees.
CELLINK has completed 7 funding rounds, raising a total of $15.94M. The latest funding stage is IPO.
Top alternatives and competitors to CELLINK include VoxCell, Carcinotech Ltd, REGEMAT 3D, Emulate, Inc., Finnadvance. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CELLINK and VoxCell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CELLINK, https://bouncewatch.com/company/cellink, updated 28 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes